Particulars |
|
|
|
Company Name
| Sanofi India Ltd
| Year End
| 202412
|
Full Year |
Equity (₹ Cr.) |
23.03 |
B.V. (₹) |
373.70 |
Sales(₹ Cr.) |
2,013.20 |
NP (₹ Cr.) |
442.27 |
NP Var (%) |
-25.00 |
Div% |
1,170.00 |
CPS(₹) |
208.00 |
EPS (₹) |
192.00 |
Traded Value(₹ Lakhs) |
25.02 |
52 Week High |
10,526.00 |
52 Week Low |
4,146.00 |
Price BSE |
6,141.00 |
Price NSE |
6,141.00 |
Market Capital (₹ Cr.) |
14,141.57 |
P/C Ratio |
29.50 |
P/E Ratio |
32.00 |
Price Vs.BV |
16.43 |
|
Latest Quarter |
Year End |
202503 |
Sales (₹ Cr.) |
535.90 |
NP(₹ Cr.) |
119.50 |
NP Var % |
10.00 |
Trailing Twelve Months |
Year End |
202503 |
Sales |
2,192.20 |
OPM |
22.35 |
NP |
421.55 |
NP Var (%) |
11.67 |
EPS |
164.93 |
PE |
37.23 |
|
|